1210 related articles for article (PubMed ID: 33723017)
1. SARS-CoV-2 infection of human iPSC-derived cardiac cells reflects cytopathic features in hearts of patients with COVID-19.
Perez-Bermejo JA; Kang S; Rockwood SJ; Simoneau CR; Joy DA; Silva AC; Ramadoss GN; Flanigan WR; Fozouni P; Li H; Chen PY; Nakamura K; Whitman JD; Hanson PJ; McManus BM; Ott M; Conklin BR; McDevitt TC
Sci Transl Med; 2021 Apr; 13(590):. PubMed ID: 33723017
[TBL] [Abstract][Full Text] [Related]
2. SARS-CoV-2 infection of human iPSC-derived cardiac cells predicts novel cytopathic features in hearts of COVID-19 patients.
Pérez-Bermejo JA; Kang S; Rockwood SJ; Simoneau CR; Joy DA; Ramadoss GN; Silva AC; Flanigan WR; Li H; Nakamura K; Whitman JD; Ott M; Conklin BR; McDevitt TC
bioRxiv; 2020 Sep; ():. PubMed ID: 32935097
[TBL] [Abstract][Full Text] [Related]
3. SARS-CoV-2 Infects Human Pluripotent Stem Cell-Derived Cardiomyocytes, Impairing Electrical and Mechanical Function.
Marchiano S; Hsiang TY; Khanna A; Higashi T; Whitmore LS; Bargehr J; Davaapil H; Chang J; Smith E; Ong LP; Colzani M; Reinecke H; Yang X; Pabon L; Sinha S; Najafian B; Sniadecki NJ; Bertero A; Gale M; Murry CE
Stem Cell Reports; 2021 Mar; 16(3):478-492. PubMed ID: 33657418
[TBL] [Abstract][Full Text] [Related]
4. Functional Effects of Cardiomyocyte Injury in COVID-19.
Siddiq MM; Chan AT; Miorin L; Yadaw AS; Beaumont KG; Kehrer T; Cupic A; White KM; Tolentino RE; Hu B; Stern AD; Tavassoly I; Hansen J; Sebra R; Martinez P; Prabha S; Dubois N; Schaniel C; Iyengar-Kapuganti R; Kukar N; Giustino G; Sud K; Nirenberg S; Kovatch P; Albrecht RA; Goldfarb J; Croft L; McLaughlin MA; Argulian E; Lerakis S; Narula J; García-Sastre A; Iyengar R
J Virol; 2022 Jan; 96(2):e0106321. PubMed ID: 34669512
[TBL] [Abstract][Full Text] [Related]
5. Tumor Necrosis Factor-Alpha Exacerbates Viral Entry in SARS-CoV2-Infected iPSC-Derived Cardiomyocytes.
Lee CY; Huang CH; Rastegari E; Rengganaten V; Liu PC; Tsai PH; Chin YF; Wu JR; Chiou SH; Teng YC; Lee CW; Liang Y; Chen AY; Hsu SC; Hung YJ; Sun JR; Chien CS; Chien Y
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576032
[TBL] [Abstract][Full Text] [Related]
6. Network pharmacology and RNA-sequencing reveal the molecular mechanism of Xuebijing injection on COVID-19-induced cardiac dysfunction.
He DD; Zhang XK; Zhu XY; Huang FF; Wang Z; Tu JC
Comput Biol Med; 2021 Apr; 131():104293. PubMed ID: 33662681
[TBL] [Abstract][Full Text] [Related]
7. Cardiac SARS-CoV-2 infection is associated with pro-inflammatory transcriptomic alterations within the heart.
Bräuninger H; Stoffers B; Fitzek ADE; Meißner K; Aleshcheva G; Schweizer M; Weimann J; Rotter B; Warnke S; Edler C; Braun F; Roedl K; Scherschel K; Escher F; Kluge S; Huber TB; Ondruschka B; Schultheiss HP; Kirchhof P; Blankenberg S; Püschel K; Westermann D; Lindner D
Cardiovasc Res; 2022 Jan; 118(2):542-555. PubMed ID: 34647998
[TBL] [Abstract][Full Text] [Related]
8. Detection of viral RNA fragments in human iPSC cardiomyocytes following treatment with extracellular vesicles from SARS-CoV-2 coding sequence overexpressing lung epithelial cells.
Kwon Y; Nukala SB; Srivastava S; Miyamoto H; Ismail NI; Jousma J; Rehman J; Ong SB; Lee WH; Ong SG
Stem Cell Res Ther; 2020 Nov; 11(1):514. PubMed ID: 33256833
[TBL] [Abstract][Full Text] [Related]
9. SARS-CoV-2 infects and induces cytotoxic effects in human cardiomyocytes.
Bojkova D; Wagner JUG; Shumliakivska M; Aslan GS; Saleem U; Hansen A; Luxán G; Günther S; Pham MD; Krishnan J; Harter PN; Ermel UH; Frangakis AS; Milting H; Zeiher AM; Klingel K; Cinatl J; Dendorfer A; Eschenhagen T; Tschöpe C; Ciesek S; Dimmeler S
Cardiovasc Res; 2020 Dec; 116(14):2207-2215. PubMed ID: 32966582
[TBL] [Abstract][Full Text] [Related]
10. SARS-Cov-2 fulminant myocarditis: an autopsy and histopathological case study.
Gauchotte G; Venard V; Segondy M; Cadoz C; Esposito-Fava A; Barraud D; Louis G
Int J Legal Med; 2021 Mar; 135(2):577-581. PubMed ID: 33392658
[TBL] [Abstract][Full Text] [Related]
11. Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes Platform to Study SARS-CoV-2 Related Myocardial Injury.
Wong CK; Luk HK; Lai WH; Lau YM; Zhang RR; Wong AC; Lo GC; Chan KH; Hung IF; Tse HF; Woo PC; Lau SK; Siu CW
Circ J; 2020 Oct; 84(11):2027-2031. PubMed ID: 32981925
[TBL] [Abstract][Full Text] [Related]
12. Myocardial injury and COVID-19: Possible mechanisms.
Babapoor-Farrokhran S; Gill D; Walker J; Rasekhi RT; Bozorgnia B; Amanullah A
Life Sci; 2020 Jul; 253():117723. PubMed ID: 32360126
[TBL] [Abstract][Full Text] [Related]
13. SARS-CoV-2, myocardial injury and inflammation: insights from a large clinical and autopsy study.
Dal Ferro M; Bussani R; Paldino A; Nuzzi V; Collesi C; Zentilin L; Schneider E; Correa R; Silvestri F; Zacchigna S; Giacca M; Metra M; Merlo M; Sinagra G
Clin Res Cardiol; 2021 Nov; 110(11):1822-1831. PubMed ID: 34282465
[TBL] [Abstract][Full Text] [Related]
14. Antiviral activity and safety of remdesivir against SARS-CoV-2 infection in human pluripotent stem cell-derived cardiomyocytes.
Choi SW; Shin JS; Park SJ; Jung E; Park YG; Lee J; Kim SJ; Park HJ; Lee JH; Park SM; Moon SH; Ban K; Go YY
Antiviral Res; 2020 Dec; 184():104955. PubMed ID: 33091434
[TBL] [Abstract][Full Text] [Related]
15. SARS-CoV-2-infected hiPSC-derived cardiomyocytes reveal dynamic changes in the COVID-19 hearts.
Li X; Hu H; Liu W; Zhang Q; Wang Y; Chen X; Zhu Y; Hu Z; Wang M; Ma J; Leng L
Stem Cell Res Ther; 2023 Dec; 14(1):361. PubMed ID: 38087340
[TBL] [Abstract][Full Text] [Related]
16. Cell-Specific Mechanisms in the Heart of COVID-19 Patients.
Tsai EJ; Cˇiháková D; Tucker NR
Circ Res; 2023 May; 132(10):1290-1301. PubMed ID: 37167361
[TBL] [Abstract][Full Text] [Related]
17. Unveiling the Antiviral Properties of Panduratin A through SARS-CoV-2 Infection Modeling in Cardiomyocytes.
Linn AK; Manopwisedjaroen S; Kanjanasirirat P; Borwornpinyo S; Hongeng S; Phanthong P; Thitithanyanont A
Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338708
[TBL] [Abstract][Full Text] [Related]
18. COVID-19-related cardiac complications from clinical evidences to basic mechanisms: opinion paper of the ESC Working Group on Cellular Biology of the Heart.
Pesce M; Agostoni P; Bøtker HE; Brundel B; Davidson SM; Caterina R; Ferdinandy P; Girao H; Gyöngyösi M; Hulot JS; Lecour S; Perrino C; Schulz R; Sluijter JP; Steffens S; Tancevski I; Gollmann-Tepeköylü C; Tschöpe C; Linthout SV; Madonna R
Cardiovasc Res; 2021 Aug; 117(10):2148-2160. PubMed ID: 34117887
[TBL] [Abstract][Full Text] [Related]
19. Association of Cardiac Infection With SARS-CoV-2 in Confirmed COVID-19 Autopsy Cases.
Lindner D; Fitzek A; Bräuninger H; Aleshcheva G; Edler C; Meissner K; Scherschel K; Kirchhof P; Escher F; Schultheiss HP; Blankenberg S; Püschel K; Westermann D
JAMA Cardiol; 2020 Nov; 5(11):1281-1285. PubMed ID: 32730555
[TBL] [Abstract][Full Text] [Related]
20. Glycated ACE2 receptor in diabetes: open door for SARS-COV-2 entry in cardiomyocyte.
D'Onofrio N; Scisciola L; Sardu C; Trotta MC; De Feo M; Maiello C; Mascolo P; De Micco F; Turriziani F; Municinò E; Monetti P; Lombardi A; Napolitano MG; Marino FZ; Ronchi A; Grimaldi V; Hermenean A; Rizzo MR; Barbieri M; Franco R; Campobasso CP; Napoli C; Municinò M; Paolisso G; Balestrieri ML; Marfella R
Cardiovasc Diabetol; 2021 May; 20(1):99. PubMed ID: 33962629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
